Study of SDX in Patients With Idiopathic Hypersomnia (IH)
Trial details
- Registry ID
- NCT05668754
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as SDX
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study of SDX in Patients With Idiopathic Hypersomnia (IH)NCT05668754 | Zevra Therapeutics | Phase 2 | Completed | 2024-02-28Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |